Differential Bio Emerges with €2M to Streamline Biomanufacturing Scale-Up

In March 2023, Munich-based AI biotech startup Differential Bio emerged from stealth with €2 million in pre-seed funding.

The company is developing a virtual scale-up platform that applies AI to simulate and optimise the transition from laboratory to industrial-scale biomanufacturing.

The technology aims to reduce the time, cost, and risk associated with scaling up production of biobased chemicals, materials, and pharmaceuticals.

By providing predictive insights and process optimisation, Differential Bio seeks to make biomanufacturing more efficient and commercially viable.

The company’s founders, with backgrounds in AI and industrial biotechnology, plan to use the funding to expand the team and accelerate platform development.

Differential Bio’s approach is positioned to support the increasing demand for sustainable biomanufacturing solutions in Europe and globally.

Sources:
03.2025
Tech.eu
Renewable Carbon News

J.V.